Postoperative radiotherapy following null-margin hepatectomy in patients with hepatocellular carcinoma adhering to the major vessels: A propensity score-matched survival analysis cohort study

被引:0
|
作者
Long, Liuhua [1 ,2 ]
Chen, Bo [2 ]
Zheng, Xuan [1 ]
Wu, Fan [3 ]
Wang, Liming [3 ]
Rong, Weiqi [3 ]
Wu, Jianxiong [3 ]
Li, Yexiong [2 ]
Wang, Weihu [1 ]
机构
[1] Peking Univ Canc Hosp & Inst, Dept Radiat Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol,Canc Hosp,Dept Radiat Onco, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Canc Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Null -Margin hepatectomy; Postoperative radiotherapy; Propensity score; Prognosis; Recurrence; LIVER RESECTION;
D O I
10.1016/j.ctro.2024.100727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background & Aims: This study aims to analyze the prognosis of null-margin (<= 1.0 mm) hepatectomy (NH) in patients with hepatocellular carcinoma (HCC) adhering to the major vessels and explore the value of postoperative radiotherapy (RT) in these patients. Methods: HCC patients who underwent null-margin or wide-margin (>= 1.0 cm) hepatectomy (WH) by our team from January 2008 to March 2016 were recruited and analyzed retrospectively. The patients were divided into the NH, NH + RT, and WH groups. Propensity score matching (PSM) was performed to balance baseline characteristics. Results: A total of 357 patients were recruited. Of these, 84, 49, and 224 patients were given NH alone, NH plus RT, and WH, respectively. After PSM, the 5-year overall survival (OS) and disease-free survival (DFS) rates of the NH group were significantly worse than those of the WH group (51.5 % vs. 71.4 %, P = 0.003; 32.2 % vs. 50.9 %, P = 0.005). The OS and DFS rates of the NH + RT group were significantly higher than those of the NH group (75.6 % vs. 56.1 %, P = 0.012; 46.6 % vs. 30.2 %, P = 0.015) and similar to those of the WH group (75.6 % vs. 75.1 %, P = 0.354; 46.6 % vs. 56.6 %, P = 0.717). In addition, patients in the NH + RT group experienced significantly lower early (P = 0.023) and intrahepatic (P = 0.015) recurrences than those in the NH group. Conclusions: Patients with HCC adhering to the major vessels who underwent NH alone had a poorer prognosis, and the addition of RT to NH provide a significant survival benefit for these patients, which may yield outcomes comparable to the efficacy of WH.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Tao, Changcheng
    Liu, Liguo
    Hu, Nan
    Wang, Hongwei
    Zhang, Kai
    Liu, Yue
    Wu, Fan
    Wang, Liming
    Rong, Weiqi
    Wu, Jianxiong
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2025, 12 : 261 - 274
  • [42] Low versus high dose of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis
    Yao, Qiwei
    Zheng, Hongying
    Huang, Shuyun
    Lin, Mingqiang
    Yang, Jun
    Li, Jiancheng
    PRECISION RADIATION ONCOLOGY, 2023, 7 (02): : 101 - 110
  • [43] Survival benefit of surgery vs radiotherapy alone to patients with stage IA lung adenocarcinoma: a propensity score-matched analysis
    Dejun Zeng
    Zhencong Chen
    Ming Li
    Yanjun Yi
    Zhengyang Hu
    Besskaya Valeria
    Guangyao Shan
    Cheng Zhan
    Junjie Xi
    Qun Wang
    Zongwu Lin
    European Journal of Medical Research, 30 (1) : 173
  • [44] Clinical outcomes of hepatocellular carcinoma patients after hepatectomy treated with TACE in combination with sorafenib: a propensity score matched analysis
    Li, Yujie
    Zhao, Ruichen
    Li, Xiao
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (05) : 1088 - 1099
  • [45] Improved survival following splenectomy combined with curative treatments for hepatocellular carcinoma in Child B patients: A propensity score matching study
    Pei, Youliang
    Zhang, Zhanguo
    Mba'nbo-koumpa, Abdoul-aziz
    Chen, Xiaoping
    Zhang, Wanguang
    HEPATOLOGY RESEARCH, 2019, 49 (02) : 177 - 188
  • [46] Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database
    Lin, Qiuyan
    Huang, Xiaoquan
    Zhong, Canmei
    Luo, Tiancheng
    Zeng, Xiaoqing
    Chen, Shiyao
    CANCER MEDICINE, 2019, 8 (02): : 515 - 526
  • [47] Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study
    Feng Xia
    Qiao Zhang
    Elijah Ndhlovu
    Jun Zheng
    Minggang Yuan
    Hengyi Gao
    Guobing Xia
    Surgical Endoscopy, 2024, 38 : 799 - 812
  • [48] Neoadjuvant conformal radiotherapy before liver transplantation for hepatocellular carcinoma: a propensity score matched analysis of postoperative morbidity and oncological results
    Mourad, Mohamed
    Mabrut, Jean-Yves
    Chellakhi, Madiha
    Lesurtel, Mickael
    Prevost, Celia
    Ducerf, Christian
    Rode, Agnes
    Merle, Philippe
    Mornex, Francoise
    Mohkam, Kayvan
    FUTURE ONCOLOGY, 2019, 15 (21) : 2517 - 2530
  • [49] Comparison of the Efficacy and Safety of Transarterial Chemoembolization Plus Microwave Ablation versus Surgical Resection in Patients with Solitary Large Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
    Zhang, Yongchao
    Chen, Hualei
    Chen, Shanshan
    Duan, Youjia
    Cheng, Long
    Gao, Jie
    Li, Wei
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 1309 - 1321
  • [50] Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study
    Wang, Fang
    Zhou, Lu
    Zhang, Li-Jun
    Xie, Chang-Bin
    Liao, Zhi-Wei
    Lin, Xiao-Dan
    Wen, Yue- Feng
    RADIOTHERAPY AND ONCOLOGY, 2024, 191